{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"submitter":["Li X"],"funding":["National Natural Science Foundation of China","Hubei Leading Talent Program in Medicine, and Wuhan Application Foundation and Frontier Project"],"pagination":["1393"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC10137658"],"repository":["biostudies-literature"],"omics_type":["Unknown"],"volume":["13(8)"],"pubmed_abstract":["<h4>Background</h4>Chromobox (CBX) proteins are essential components of polycomb group proteins and perform essential functions in bladder cancer (BLCA). However, research on CBX proteins is still limited, and the function of CBXs in BLCA has not been well illustrated.<h4>Methods and results</h4>We analyzed the expression of CBX family members in BLCA patients from The Cancer Genome Atlas database. By Cox regression analysis and survival analysis, CBX6 and CBX7 were identified as potential prognostic factors. Subsequently, we identified genes associated with CBX6/7 and performed enrichment analysis, and they were enriched in urothelial carcinoma and transitional carcinoma. Mutation rates of TP53 and TTN correlate with expression of CBX6/7. In addition, differential analysis indicated that "],"journal":["Diagnostics (Basel, Switzerland)"],"pubmed_title":["Identification of the Prognostic Biomarkers CBX6 and CBX7 in Bladder Cancer."],"pmcid":["PMC10137658"],"funding_grant_id":["No. 2020020601012209","No. 81770688"],"pubmed_authors":["Li X","Luo P","Kuang Q","Zhu K","Li L","Peng M","Xiong X"],"additional_accession":[]},"is_claimable":false,"name":"Identification of the Prognostic Biomarkers CBX6 and CBX7 in Bladder Cancer.","description":"<h4>Background</h4>Chromobox (CBX) proteins are essential components of polycomb group proteins and perform essential functions in bladder cancer (BLCA). However, research on CBX proteins is still limited, and the function of CBXs in BLCA has not been well illustrated.<h4>Methods and results</h4>We analyzed the expression of CBX family members in BLCA patients from The Cancer Genome Atlas database. By Cox regression analysis and survival analysis, CBX6 and CBX7 were identified as potential prognostic factors. Subsequently, we identified genes associated with CBX6/7 and performed enrichment analysis, and they were enriched in urothelial carcinoma and transitional carcinoma. Mutation rates of TP53 and TTN correlate with expression of CBX6/7. In addition, differential analysis indicated that ","dates":{"release":"2023-01-01T00:00:00Z","publication":"2023 Apr","modification":"2025-04-22T05:13:43.801Z","creation":"2025-04-05T21:14:39.697Z"},"accession":"S-EPMC10137658","cross_references":{"pubmed":["37189494"],"doi":["10.3390/diagnostics13081393"]}}